You are here

Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

Last updated on December 5, 2018

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Muenchen, , 80337 Germany
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Plaque Psoriasis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Proven diagnosis of Plaque Psoriasis

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Contraindications according to SmPC of Enbrel

NCT00227240
Pfizer
Completed
Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.

Similar Trials

Psoriasis
NCT01300052
All Genders
18+
Years
Multiple Sites
Psoriatic Arthritis, Psoriasis
NCT00998829
All Genders
18+
Years
Multiple Sites
Psoriasis
NCT01029405
All Genders
18+
Years
Multiple Sites
Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis
Observational Study With Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis
The purpose of this study is to investigate the incidences of adverse events for patients with plaque psoriasis treated with Enbrel under usual care settings.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
primary care clinical and community sample
Plaque Psoriasis
Not Provided
Not Provided
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
753
June 2009
June 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Proven diagnosis of Plaque Psoriasis

Exclusion Criteria:

  • Contraindications according to SmPC of Enbrel
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
 
NCT00227240
0881A-101789
Not Provided
Not Provided
Not Provided
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
March 2012

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now